Search: id:"swepub:oai:DiVA.org:uu-515591" >
Positive airway pre...
Positive airway pressure treatment affects respiratory symptoms and gastro-oesophageal reflux : the Icelandic Sleep Apnea Cohort Study
-
- Emilsson, Össur Ingi (author)
- Uppsala universitet,Lung- allergi- och sömnforskning,Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
-
- Aspelund, Thor (author)
- Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.
-
- Janson, Christer (author)
- Uppsala universitet,Lung- allergi- och sömnforskning
-
show more...
-
- Benediktsdottir, Bryndis (author)
- Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
-
- Juliusson, Sigurdur (author)
- Landspitali Natl Univ Hosp Iceland, Dept Otolaryngol, Reykjavik, Iceland.;Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
-
- Maislin, Greg (author)
- Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
-
- Pack, Allan I. (author)
- Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
-
- Keenan, Brendan T. (author)
- Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
-
- Gislason, Thorarinn (author)
- Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
-
show less...
-
(creator_code:org_t)
- European Respiratory Society, 2023
- 2023
- English.
-
In: ERJ Open Research. - : European Respiratory Society. - 2312-0541. ; 9:5
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Aim: To study the effect of positive airway pressure (PAP) treatment on nocturnal gastro-oesophageal reflux (nGOR) and respiratory symptoms among clinical obstructive sleep apnoea (OSA) patients.Methods: 822 patients newly diagnosed with OSA referred for PAP treatment were recruited. 732 patients had a 2-year follow-up visit with continuous PAP compliance data (366 full PAP users, 366 partial/non-PAP users). They answered questionnaires, including reporting of nGOR, sleep and respiratory symptoms and general health. Patients with nGOR symptoms once a week or more were defined as "with nGOR". Those without nGOR symptoms and nGOR medication were defined as "no nGOR". Others were defined as "possible nGOR".Results: At 2-year follow-up, PAP treatment among full users resulted in decreased nGOR (adjusted OR 0.58, 95% CI 0.40-0.86) and wheezing (adjusted OR 0.56, 95% CI 0.35-0.88) compared with partial/non-PAP users. Decreased nGOR, among both full and partial/non-users of PAP treatment, was associated with a decrease in productive morning cough (adjusted OR 4.70, 95% CI 2.22-9.99) and a decrease in chronic bronchitis (adjusted OR 3.86, 95% CI 1.74-8.58), but not decreased wheezing (adjusted OR 0.90, 95% CI 0.39-2.08). A mediation analysis found that PAP treatment directly led to a decrease in wheezing, not mediated through nGOR. Conversely, PAP treatment decreased productive cough mediated through a decrease in nGOR.Conclusion: In an unselected group of OSA patients, PAP treatment for 2 years was associated with a decrease in nGOR and respiratory symptoms. The PAP treatment itself was associated with less wheezing. A decrease in nGOR through PAP treatment was associated with a decrease in productive cough.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database